Barclays PLC Iterum Therapeutics PLC Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$0.97 - $2.39 $48,500 - $119,500
-50,000 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$0.97 - $2.73 $48,500 - $136,500
50,000 New
50,000 $71,000
Q4 2020

Feb 11, 2021
SELL
$0.46 - $1.2 $18,400 - $48,000
-40,000 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$0.58 - $1.22 $23,200 - $48,800
40,000 New
40,000 $42,000

Others Institutions Holding ITRM

# of Institutions
3
Shares Held
145
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $24.7M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email